Cameroon vs Namibia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Cameroon
82.0%
in 2025
Namibia
83.0%
in 2025
Cameroon rank
106th
Namibia rank
104th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Cameroon
- Namibia
How they compare
Namibia currently reports 83.0% against 82.0% in Cameroon, a difference of 1.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Namibia ahead.
Cameroon ranks 106th and Namibia ranks 104th of 194 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Namibia in 1.
Head to head by decade
| Decade | Cameroon | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 62.2% | 35.0% | 27.2% | Cameroon |
| 2020s | 73.7% | 80.7% | 7.0% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Cameroon or Namibia?
- Namibia, at 83.0% against 82.0% in Cameroon as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Cameroon and Namibia?
- 1.0%, with Namibia ahead.
- How many years of comparable data are there for Cameroon and Namibia?
- 18 years are reported by both, from 2008 to 2025.
- How do Cameroon and Namibia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cameroon ranks 106th and Namibia ranks 104th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.